Discovery of novel, orally active dual NK1/NK2 antagonists

This publication has 12 references indexed in Scilit:

• Role of tachykinins as contractile agonists of human airways in asthma
  Clinical and Experimental Allergy, 1999
• Chapter 6. Progress in the Development of Neurokinin Antagonists
  Published by Elsevier ,1999
• Dual neurokinin NK1/NK2 receptor antagonists
  Drugs of the Future, 1999
• Structural Optimization Affording 2-(R)-(1-(R)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist
  Journal of Medicinal Chemistry, 1998
• Identification and chemical synthesis of MDL 105,212, a non-peptide tachykinin antagonist with high affinity for NK1 and NK2 receptors
  Bioorganic & Medicinal Chemistry Letters, 1996
• In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma.
  Journal of Clinical Investigation, 1996
• Regioselective Monomethylation of Unsymmetrical Naphthalenediols With Methanolic HCl
  Australian Journal of Chemistry, 1993
• A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptor
  Life Sciences, 1992
• Study of reactions leading to sulfine formation. Competition of reaction pathways in the reaction of methoxide ion with methyl 1-naphthylmethanesulfinates
  The Journal of Organic Chemistry, 1989
• Substituent Effects. VIII.¹ Synthesis of Substituted α- and β-Fluoronaphthalenes²
  Journal of the American Chemical Society, 1967